Innovating Works

ALBIRAL DISPLAY SOLUTIONS

Activa
IT4B-ALL: Therapeutic immunotherapy targeting NG2 and CD22 antigens for MLL rearranged and MLL germline B cell... FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS tramitó un H2020: ERC-2018-PoC B-ALL is the commonest cancer of childhood. There remain childhood B-ALL subgroups with dismal prognosis such as infant B-ALL and B-ALL carr...
2018-09-17 - 2020-06-30 | Financiado
LEA: LEARNING TECHNOLOGY ACCELERATOR JYVASKYLAN YLIOPISTO tramitó un H2020: H2020-ICT-2016-2017 " Based upon the finding from IMAILE PCP of Innovative STEM/PLE (www.imaile.eu), the project LEARNTECH ACCELERATOR ( LEA) will take a quant...
2017-11-24 - 2020-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.